Dongfang Lue
PrivateLast Round
Private Equity
Dec 23, 2019
Est. Valuation
$185.9M
Total Funding Raised
$42.9M
Company Overview
Dongfang Lue is a biopharmaceutical company focused on the research and development of DNA-based vaccines and therapies, notably for HPV-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, News & Media, Event Management
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dongfang Lue Comparables
Compare Dongfang Lue with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioon | 87% | |
| ChinaBio Group | 84% | |
| Pharnex | 84% |
Dongfang Lue Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Dec 23, 2019 | ||||
| Series B | Jun 19, 2018 | ||||
| Private Placement | Jan 13, 2017 | ||||
| Private Placement | Jun 1, 2016 | ||||
| Private Placement | Feb 29, 2016 | ||||
Angel | Jul 18, 2006 |
Dongfang Lue Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NewMargin Ventures | Private Placement |
| 5Y Capital | Angel |
| Beijing Dongfang Gaosheng Holding Co., Ltd. | Private Placement, Angel |
| Xingkong Capital | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2019
$43M round raised at $186M post-money valuation.
- Jun 19, 2018
Completed Series B funding round.
Dongfang Lue Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dongfang Lue's valuation, stock price, and market status.
Is Dongfang Lue a public or private company?
Dongfang Lue is a private company.
What is the current stock price of Dongfang Lue?
Dongfang Lue is a private company, so its shares have no public market price. Caplight tracks Dongfang Lue's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dongfang Lue worth (valuation)?
Dongfang Lue's valuation is estimated at $185.9M based on funding round data.
Can I buy Dongfang Lue stock?
Dongfang Lue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dongfang Lue's last funding round?
Dongfang Lue's most recent funding round was Private Equity on December 23, 2019.
Who are the main investors in Dongfang Lue?
Key investors in Dongfang Lue include Beijing Dongfang Gaosheng Holding Co., Ltd..
Will Dongfang Lue IPO soon?
No public IPO plans have been announced for Dongfang Lue.
How can I track Dongfang Lue secondary market activity?
Caplight tracks bids, offers, and trades in Dongfang Lue's shares on secondary markets.